Routine buyback disclosure with no new strategic information. Monitor for any changes in buyback pace or program size, which could signal management's view on valuation. The program has ~DKK 9.4 billion remaining capacity through February 2027.
Price Chart
Executive Summary
Novo Nordisk filed a routine 6-K disclosing weekly B-share repurchase transactions under its existing DKK 15 billion buyback program. The company repurchased 1,075,000 B shares for ~DKK 307.9 million during the week ending June 19, 2026, bringing the total under the program to 6,200,000 shares for ~DKK 1.78 billion. This is a routine capital allocation update with no material new information.
Key Facts
- Novo Nordisk repurchased 1,075,000 B shares from June 15-19, 2026, for ~DKK 307.9 million
- Total repurchased under the program initiated May 6, 2026: 6,200,000 B shares for ~DKK 1.78 billion
- Overall 12-month buyback program of up to DKK 15 billion began February 4, 2026; total repurchased since then: 20,959,179 B shares for ~DKK 5.58 billion
- Company now holds 38,144,480 B shares as treasury shares, representing 0.9% of share capital
Financial Impact
DKK 307.9 million in weekly repurchases; total DKK 5.58 billion deployed YTD under the DKK 15 billion program
Risk Factors
- No material risk identified from this routine filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004275 |
| Document: 0001171843-26-004275-index-headers.html | 0001171843-26-004275 |
| Document: 0001171843-26-004275-index.html | 0001171843-26-004275 |
| Document: 0001171843-26-004275.txt | 0001171843-26-004275 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $39.00 | awaiting T+20 | — | $38.67 (−0.85%) |
Oct 19, 2026 8d ago | 6-K | $38.42 | awaiting T+20 | — | $38.67 (+0.64%) |
Oct 13, 2026 14d ago | 6-K | $38.06 | awaiting T+20 | — | $38.67 (+1.59%) |
Oct 6, 2026 21d ago | 6-K | $37.53 | awaiting T+20 | — | $38.67 (+3.02%) |
Sep 28, 2026 29d ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $38.67 (−0.12%) |
Sep 23, 2026 4w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $38.67 (+0.12%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $38.67 (−2.85%) |
Sep 17, 2026 5w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $38.67 (−10.48%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $38.67 (−9.09%) |
Sep 9, 2026 6w ago | 6-K | $44.56 $38.26 | ▼ −14.14% | ▼ −16.08% | $38.67 (−13.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers